Form 4: Medtronic Executive Sells Shares for Tax Obligations

Medtronic EVP Michael Marinaro disposed of 1,371 ordinary shares to cover tax liabilities related to restricted stock unit vesting.

Summary

• Michael Marinaro, EVP, Pres MedSurg and Americas at Medtronic plc, disposed of 1,371 ordinary shares.
• The transaction occurred on December 15, 2025, at a price of $99.87 per share.
• These shares were withheld for the payment of taxes upon the vesting of restricted stock units.
• The vesting was triggered by Mr. Marinaro's retirement eligibility.
• Following this transaction, Mr. Marinaro beneficially owns 50,818 ordinary shares.
• This total includes 250 shares acquired through dividend reinvestment since the last report.

Sentiment

Score: 5

Explanation: Neutral. The transaction is a routine, non-discretionary sale for tax purposes related to equity compensation, which is a common occurrence for executives.

Positives

• The executive's remaining beneficial ownership of 50,818 shares indicates continued alignment with shareholder interests.
• Acquisition of 250 shares through dividend reinvestment shows ongoing participation in the company's equity.

Negatives

• Disposal of 1,371 shares, even for tax purposes, reduces the executive's direct equity stake.

Future Outlook

NA

Industry Context

This is a routine insider transaction for tax purposes, common across all industries for executives receiving equity compensation. It does not reflect broader industry trends or competitive positioning.

Comparison to Industry Standards

• This is a standard tax-related share disposition, a common practice for executives across publicly traded companies (e.g., Apple, Johnson & Johnson, Pfizer) when restricted stock units vest. The transaction itself is not indicative of performance relative to industry peers but rather a compliance event related to executive compensation structures.

Management Changes

Stakeholder Impact

• Shareholders: Minimal direct impact. The transaction is a routine tax-related sale and does not signal a change in company fundamentals or executive confidence. The executive still holds a significant number of shares.
• Employees: No direct impact.
• Customers/Suppliers/Creditors: No direct impact.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by an executive to cover tax obligations upon the vesting of restricted stock units. Such transactions are common and do not typically reflect a change in the executive's confidence in the company or its future prospects. The executive retains a substantial beneficial ownership, and the event itself provides no new fundamental information to warrant a change in investment thesis. Therefore, a "hold" recommendation is appropriate as this filing does not present a reason to alter an existing position.

Keywords

Medtronic, MDT, SEC Form 4, Insider Transaction, Share Sale, Tax Withholding, Restricted Stock Units, Executive Compensation, Michael Marinaro